Underestimation of hypoglycaemia using patients' diaries compared with downloaded glucometer data: an ITAS post hoc analysis

Minimizing hypoglycaemia when initiating basal insulin treatment in type 2 diabetes (T2D) is as important as assessing its efficacy in lowering HbA1c. Hypoglycaemic events are often under-reported by people treated with insulin, as indicated by studies comparing the occurrence of hypoglycaemia based on continuous glucose monitoring (CGM) with that based on less comprehensive self-monitored plasma glucose (SMPG).1-3 CGM is not yet routinely used...